From 361bc4a87ea8a0de70e3a6ce2952554b4e66695f Mon Sep 17 00:00:00 2001 From: =?UTF-8?q?Emmanuel=20B=C3=A9ziat?= Date: Thu, 27 May 2021 19:26:30 +0200 Subject: [PATCH] Update pfizer --- vaccins/pfizer.md | 7 ++++++- 1 file changed, 6 insertions(+), 1 deletion(-) diff --git a/vaccins/pfizer.md b/vaccins/pfizer.md index d5534c7..ba04f6f 100644 --- a/vaccins/pfizer.md +++ b/vaccins/pfizer.md @@ -72,7 +72,7 @@ ![Pfizer-BioNTech and AstraZeneca, Oxford Vaccine effectiveness in over 70s](../graphs/msedge_wHYBNSH4e2.jpg) -[Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England](https://khub.net/documents/135939561/430986542/Early+effectiveness+of+COVID+vaccines.pdf/ffd7161c-b255-8e88-c2dc-88979fc2cc1b?t=1614617945615) — Public Health England +* [Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England](https://khub.net/documents/135939561/430986542/Early+effectiveness+of+COVID+vaccines.pdf/ffd7161c-b255-8e88-c2dc-88979fc2cc1b?t=1614617945615) — Public Health England * [The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine](https://www.cdc.gov/mmwr/volumes/69/wr/mm6950e2.htm?s_cid=mm6950e2_w) — CDC, 18 Décembre 2020 ### Israël @@ -83,8 +83,13 @@ Le vaccin Pfizer montre une bonne efficacité contre les variants B.1.1.7 (dit "anglais") et B.1.351 (dit "africain") +* [Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants](https://www.nejm.org/doi/10.1056/NEJMc2104974) — NEJM, 5 Mai 2021 * [BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans](https://www.nature.com/articles/s41586-021-03653-6) — Nature, 27 Mai 2021 +## Autres études + +* [BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting](https://www.nejm.org/doi/full/10.1056/NEJMoa2101765) — NEJM, 15 Avril 2021 + ## Autorisations et recommandations | Pays / Zone | Document(s) |